Drug recall D-0611-2026

Class II Ongoing reported Jul 1, 2026

Product

Fenofibrate Capsules, USP 200 mg, Rx only, 100 Capsules, Manufactured by: Ajanta Pharma Limited, India, Marketed by: Ajanta Pharma USA Inc. Bridgewater, NJ 08807, NDC 27241-120-04.

Reason for recall

CGMP Deviations

Lots and codes

Lot # PA02216; Exp. 12/2029

Recall details

Recalling firm
Ajanta Pharma USA Inc, Bridgewater, NJ
Quantity
3648 bottles
Distribution
U.S. Nationwide
Type
Voluntary: Firm initiated
Recall initiated
May 28, 2026

Related products